Ticker
ORGOCompany Name
ORGANOGENESIS HOLDINGS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -33.18M | -7.72% | $ 429.53M |
3/31/2025 | $ 4.43M | 0.97% | $ 458.76M |
12/31/2024 | $ 14.21M | 2.95% | $ 482.04M |
9/30/2024 | $ 13.88M | 3.05% | $ 455.04M |
6/30/2024 | $ 21.92M | 4.89% | $ 448.39M |
3/31/2024 | $ 25.83M | 5.93% | $ 435.47M |
12/31/2023 | $ 30.92M | 7.14% | $ 433.14M |
9/30/2023 | $ 28.1M | 6.26% | $ 449M |
6/30/2023 | $ 16.82M | 3.68% | $ 457.33M |
3/31/2023 | $ 18.37M | 3.98% | $ 461.42M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ORGANOGENESIS HOLDINGS INC is calculated as follows: CF - Operations [ $ -25.88M ] / Revenues [ $ 306.14M ]
(=) OCF % [ -8.45% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |